Indian Army Medical Goods Tender 2025: Syp Tixilix 60 ml, Lignocaine 2% with Adrenaline 1:80000 30 ml, Metoclopramide 10 mg, Leuprolide 3.75 mg, Dextrose 25% 25 ml, Amlodipine 10 mg, Dexamethasone 4 mg, Glass Tiles for Blood Grouping 10x8, Lactic Acid Bacillus – 47976.22

Tender Overview

Organization: Indian Army (Department Of Military Affairs) seeks procurement of a range of medical consumables and related items, including Syp Tixilix 60 ml bottle, Lignocaine HCl 2% with Adrenaline 1:80000 30 ml injection, Metoclopramide 10 mg tablets, Leuprolide 3.75 mg injections, Amlodipine 10 mg tablets, Dexamethasone 4 mg, Glass Tiles for rapid Blood Grouping 10 x 8 cavity, Dextrose Injection 25% 25 ml, and Lactic Acid Bacillus sachets. Estimated value is ₹47,976.22. Location is not disclosed; this tender targets military medical supply needs and basic hospital infrastructure. The scope includes multiple pharmaceutical and diagnostic items with a blended procurement approach. A key differentiator is the mix of injectable, tablet, and diagnostic components in a single procurement event.

Technical Specifications & Requirements

• Product/service names: Syp Tixilix bottle (60 ml), Lignocaine HCl 2% with Adrenaline 1:80000 (30 ml), Metoclopramide 10 mg tablets, Leuprolide 3.75 mg injections, Amlodipine 10 mg tablets, Dexamethasone 4 mg, Glass Tiles for rapid Blood Grouping (10x8 cavity), Dextrose Injection 25% (25 ml), Lactic Acid Bacillus sachets.
• Estimated value: ₹47,976.22.
• Delivery/installation context: Delivery period terms present in option clause; extension logic defined if quantity varies up to 25%.
• Quality/standards: No explicit technical standards provided in the data; bidders should rely on standard pharmaceutical validation, supplier certifications, and OEM authorizations where applicable.
• Experience/eligibility indicators: OEM/Turnover requirements referenced but not numerically specified in data; bidders must meet documentary turnover proof and attest to OEM support in India for imported items.
• Notes: The BoQ shows 9 items, but no detailed item specs beyond the names; prepare item-wise documentation, including batch/pack details where applicable.

Terms, Conditions & Eligibility

• EMD: Not specified in data; bidders should verify exact EMD in bid document.
• Turnover requirements: Bidder must provide minimum average annual turnover for last 3 years as per bid document; OEM turnover criteria similarly required for offered product.
• GST: Bidder must determine applicable GST; GST reimbursement will be as per actuals or applicable rates, whichever is lower, up to quoted GST percentage.
• Imported products: If any item is imported, OEM must have registered office in India for after-sales service; submit certificate.
• Delivery timeline: Option clause allows quantity variation and modified delivery periods; delivery time extends proportionally with quantity changes, subject to minimum 30 days.
• Documentation: Provide audited financials or CA certificate for turnover; provide OEM authorizations and technical compliance documents; submit GST, PAN, and experience certificates as applicable.
• Warranty/After-sales: Not explicitly stated; bidders should infer standard pharma/medical item warranties and service support from OEM where applicable.
• Compliance: All terms require bidder compliance with option clause and GST rules; ensure readiness for multi-item procurement with mixed formats.